INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
Were the SARS-CoV-2 sterile injectables a rebranding of CAR T gene therapies that weren’t selling?

Were the SARS-CoV-2 sterile injectables a…

Hedley Rees
Oct 4, 2024
11

Share this post

INSIDE PHARMA
INSIDE PHARMA
Were the SARS-CoV-2 sterile injectables a rebranding of CAR T gene therapies that weren’t selling?
7
2

This thread is only visible to paid subscribers of INSIDE PHARMA

Subscribe to view →

Comments on this post are for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share